The December in-vivo lab builds on Vicarious Surgical's disciplined, specification-driven development approach and reflects the company's focus on minimizing technical risk through iterative testing, ...
Throughout his Ph.D. research, Narechania held fast to the belief that human decisions are best guided by data. Better data ...
11h
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback